GOLDMAN SACHS GROUP INC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 47 filers reported holding IRADIMED CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$2,488,092
+11.0%
56,076
+19.4%
0.00%
Q2 2023$2,242,205
+17.2%
46,967
-3.4%
0.00%
Q1 2023$1,912,606
+22.4%
48,605
-12.0%
0.00%
Q4 2022$1,563,023
+12.9%
55,250
+19.9%
0.00%
Q3 2022$1,385,000
+9.1%
46,066
+23.1%
0.00%
Q2 2022$1,270,000
-18.0%
37,423
+8.5%
0.00%
Q1 2022$1,548,000
+134.9%
34,505
+142.3%
0.00%
Q4 2021$659,000
+35.6%
14,240
-1.6%
0.00%
Q3 2021$486,000
+131.4%
14,471
+102.5%
0.00%
Q2 2021$210,000
-19.8%
7,145
-23.5%
0.00%
Q1 2019$262,000
-13.2%
9,344
-24.4%
0.00%
Q4 2018$302,000
-18.2%
12,363
+24.5%
0.00%
Q3 2018$369,000
+49.4%
9,930
-16.6%
0.00%
Q2 2018$247,000
-14.8%
11,901
-63.5%
0.00%
Q1 2017$290,000
+28.3%
32,619
+252.1%
0.00%
Q3 2015$226,000
-22.9%
9,263
-26.4%
0.00%
Q2 2015$293,000
+24.7%
12,585
-18.3%
0.00%
Q1 2015$235,000
+18.1%
15,404
+0.0%
0.00%
Q4 2014$199,000
+41.1%
15,403
-23.4%
0.00%
Q3 2014$141,00020,1060.00%
Other shareholders
IRADIMED CORP shareholders Q3 2015
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders